Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05501912
What this trial is testing

ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Shanghai Company Limited 20
Testing effectiveness (Phase 2)Study completedNCT01187836
What this trial is testing

Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure

Who this might be right for
Heart Failure
Trevena Inc. 33
Early research (Phase 1)Active Not RecruitingNCT05646836
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 90
Early research (Phase 1)Study completedNCT02410512
What this trial is testing

Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 610
Early research (Phase 1)Ended earlyNCT02138812
What this trial is testing

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Who this might be right for
Medical Oncology
Bayer 69
Early research (Phase 1)Study completedNCT03013881
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers

Who this might be right for
Breast Neoplasm
United BioPharma 18
Early research (Phase 1)Ended earlyNCT00543972
What this trial is testing

Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia

Who this might be right for
Myeloid Leukemia
Sanofi 12
Early research (Phase 1)Study completedNCT01345357
What this trial is testing

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Who this might be right for
Solid Tumors or Mantle Cell Lymphoma
Cephalon 24
Testing effectiveness (Phase 2)Study completedNCT00160212
What this trial is testing

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

Who this might be right for
Hypertension
Solvay Pharmaceuticals
Early research (Phase 1)Study completedNCT04266028
What this trial is testing

Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy

Who this might be right for
Birch Pollen Allergy
Desentum Oy 27
Early research (Phase 1)Study completedNCT00992758
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 11
Early research (Phase 1)Study completedNCT00354926
What this trial is testing

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Applied Molecular Evolution 67
Testing effectiveness (Phase 2)Ended earlyNCT01165450
What this trial is testing

Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

Who this might be right for
Persistent Corneal Epithelial Defects
University of California, San Francisco 2
Testing effectiveness (Phase 2)Ended earlyNCT01573247
What this trial is testing

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akinion Pharmaceuticals AB 25
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Early research (Phase 1)Study completedNCT04879849
What this trial is testing

TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck
Takeda 34
Early research (Phase 1)Study completedNCT04096638
What this trial is testing

Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaSolid Tumor
invoX Pharma Limited 61
Early research (Phase 1)Study completedNCT00482989
What this trial is testing

Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus
MedImmune LLC 183
Early research (Phase 1)Study completedNCT04544748
What this trial is testing

GNR-051 in Subjects With Advanced Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma
AO GENERIUM 48
Early research (Phase 1)Study completedNCT01301443
What this trial is testing

Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
Oxford BioMedica 21
Next Page